Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. Th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ricardo Mora
Collaborators
NCT07410325 · Metabolic Syndrome (MetS), Metabolic Syndrome
NCT07051733 · Metabolic Syndrome (MetS)
NCT06992453 · Recurrent C. Difficile (rCDI), Ulcerative Colitis (UC), and more
NCT05145049 · Intracranial Neoplasm, Hyperlactatemia, and more
NCT05507528 · LIPOLYSIS
Facultad de Ciencias del Deporte
San Javier, Murcia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions